Literature DB >> 21069450

Circulating levels of inflammatory markers and mammographic density among postmenopausal women.

Katherine W Reeves1, Joel L Weissfeld, Francesmary Modugno, Brenda Diergaarde.   

Abstract

Mammographic density is strongly associated with breast cancer risk. Inflammation is involved in breast carcinogenesis, perhaps through effects on mammographic density. We evaluated associations between inflammatory markers interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α), and C-reactive protein (CRP) and mammographic density among postmenopausal women. Plasma IL-6, TNF-α, and CRP levels were measured in 145 women with benign breast disease (benign controls) and 397 women with a negative screening mammogram (well controls) enrolled in the Mammograms and Masses Study. Associations between the inflammatory markers and mammographic density were evaluated separately for benign and well controls through correlation analyses and linear regressions. Age-adjusted mean CRP levels were higher among benign controls (2.07 μg/ml) compared to well controls (1.63 μg/ml; P = 0.02), while IL-6 and TNF-α levels were similar between groups. Using linear regression, IL-6, TNF-α, and CRP were not statistically significantly associated with dense breast area within either group. Statistically significant positive associations were observed between all three markers and nondense breast area in both groups; statistically significant negative associations were observed between IL-6 and percent density among benign controls, and between all three markers and percent density among well controls. These associations were all attenuated and non-significant upon adjustment for body mass index. IL-6, TNF-α, and CRP levels were not independently associated with dense breast area, nondense breast area, or percent density in this study population. Our results suggest that these inflammatory factors do not impact breast carcinogenesis through independent effects on mammographic density.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21069450      PMCID: PMC3431555          DOI: 10.1007/s10549-010-1249-5

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  52 in total

1.  Mammographic density changes during the menstrual cycle.

Authors:  G Ursin; Y R Parisky; M C Pike; D V Spicer
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2001-02       Impact factor: 4.254

2.  Postmenopausal hormone therapy and change in mammographic density.

Authors:  Gail A Greendale; Beth A Reboussin; Stacey Slone; Carol Wasilauskas; Malcolm C Pike; Giske Ursin
Journal:  J Natl Cancer Inst       Date:  2003-01-01       Impact factor: 13.506

3.  Mammographic density correlation with Gail model breast cancer risk estimates and component risk factors.

Authors:  Melanie R Palomares; Joelle R B Machia; Constance D Lehman; Janet R Daling; Anne McTiernan
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2006-07       Impact factor: 4.254

4.  Obesity, body size, and risk of postmenopausal breast cancer: the Women's Health Initiative (United States).

Authors:  Libby M Morimoto; Emily White; Z Chen; Rowan T Chlebowski; Jennifer Hays; Lewis Kuller; Ana Marie Lopez; JoAnn Manson; Karen L Margolis; Paola C Muti; Marcia L Stefanick; Anne McTiernan
Journal:  Cancer Causes Control       Date:  2002-10       Impact factor: 2.506

5.  Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies.

Authors:  T Key; P Appleby; I Barnes; G Reeves
Journal:  J Natl Cancer Inst       Date:  2002-04-17       Impact factor: 13.506

6.  Nonsteroidal anti-inflammatory drug use and breast cancer risk.

Authors:  M Cotterchio; N Kreiger; M Sloan; A Steingart
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2001-11       Impact factor: 4.254

7.  Heritability of mammographic density, a risk factor for breast cancer.

Authors:  Norman F Boyd; Gillian S Dite; Jennifer Stone; Anoma Gunasekara; Dallas R English; Margaret R E McCredie; Graham G Giles; David Tritchler; Anna Chiarelli; Martin J Yaffe; John L Hopper
Journal:  N Engl J Med       Date:  2002-09-19       Impact factor: 91.245

8.  No association between serum levels of tumor necrosis factor-alpha (TNF-alpha) or the soluble receptors sTNFR1 and sTNFR2 and breast cancer risk.

Authors:  Rozlyn A Krajcik; Stephen Massardo; Norman Orentreich
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2003-09       Impact factor: 4.254

Review 9.  Regulation of estrogen synthesis in postmenopausal women.

Authors:  Atul Purohit; Michael J Reed
Journal:  Steroids       Date:  2002-11       Impact factor: 2.668

10.  Breast cancer and nonsteroidal anti-inflammatory drugs: prospective results from the Women's Health Initiative.

Authors:  Randall E Harris; Rowan T Chlebowski; Rebecca D Jackson; David J Frid; Joao L Ascenseo; Garnet Anderson; Aimee Loar; Rebecca J Rodabough; Emily White; Anne McTiernan
Journal:  Cancer Res       Date:  2003-09-15       Impact factor: 12.701

View more
  10 in total

1.  Inflammation and breast density among female Chinese immigrants: exploring variations across neighborhoods.

Authors:  Carolyn Y Fang; Brian L Egleston; Celia Byrne; Gregory S Bohr; Harsh B Pathak; Andrew K Godwin; Philip T Siu; Marilyn Tseng
Journal:  Cancer Causes Control       Date:  2019-08-07       Impact factor: 2.506

2.  Gut microbiome, body weight, and mammographic breast density in healthy postmenopausal women.

Authors:  Lusine Yaghjyan; Volker Mai; Xuefeng Wang; Maria Ukhanova; Maximiliano Tagliamonte; Yessica C Martinez; Shannan N Rich; Kathleen M Egan
Journal:  Cancer Causes Control       Date:  2021-03-27       Impact factor: 2.506

3.  Association between high-sensitivity C-reactive protein (hsCRP) and change in mammographic density over time in the SWAN mammographic density subcohort.

Authors:  Kunlanat Makboon; Ellen B Gold; Danielle J Harvey; Lesley M Butler; Laurel A Habel
Journal:  Cancer Causes Control       Date:  2015-01-21       Impact factor: 2.506

4.  High mammographic density is associated with an increase in stromal collagen and immune cells within the mammary epithelium.

Authors:  Cecilia W Huo; Grace Chew; Prue Hill; Dexing Huang; Wendy Ingman; Leigh Hodson; Kristy A Brown; Astrid Magenau; Amr H Allam; Ewan McGhee; Paul Timpson; Michael A Henderson; Erik W Thompson; Kara Britt
Journal:  Breast Cancer Res       Date:  2015-06-04       Impact factor: 6.466

5.  Similarity of fibroglandular breast tissue content measured from magnetic resonance and mammographic images and by a mathematical algorithm.

Authors:  Fatima Nayeem; Hyunsu Ju; Donald G Brunder; Manubai Nagamani; Karl E Anderson; Tuenchit Khamapirad; Lee-Jane W Lu
Journal:  Int J Breast Cancer       Date:  2014-07-15

6.  Genetic Variations in VDR could Modulate the Efficacy of Vitamin D3 Supplementation on Inflammatory Markers and Total Antioxidant Capacity among Breast Cancer Women: A Randomized Double Blind Controlled Trial.

Authors:  Houra Mohseni; Reza Amani; Seyed Ahmad Hosseini; Alireza Ekrami; Ahmad Ahmadzadeh; Seyed Mahmoud Latifi
Journal:  Asian Pac J Cancer Prev       Date:  2019-07-01

7.  Inflammatory marker changes in a 24-month dietary and physical activity randomised intervention trial in postmenopausal women.

Authors:  G Masala; B Bendinelli; C Della Bella; M Assedi; S Tapinassi; I Ermini; D Occhini; M Castaldo; C Saieva; S Caini; M M D'Elios; D Palli
Journal:  Sci Rep       Date:  2020-12-14       Impact factor: 4.379

8.  Variation in inflammatory cytokine/growth-factor genes and mammographic density in premenopausal women aged 50-55.

Authors:  Ali Ozhand; Eunjung Lee; Anna H Wu; Merete Ellingjord-Dale; Lars A Akslen; Roberta McKean-Cowdin; Giske Ursin
Journal:  PLoS One       Date:  2013-06-07       Impact factor: 3.240

9.  Polymorphisms in hormone metabolism and growth factor genes and mammographic density in Norwegian postmenopausal hormone therapy users and non-users.

Authors:  Merete Ellingjord-Dale; Eunjung Lee; Elisabeth Couto; Ali Ozhand; Samera Qureshi; Solveig Hofvind; David J Van Den Berg; Lars A Akslen; Tom Grotmol; Giske Ursin
Journal:  Breast Cancer Res       Date:  2012-10-27       Impact factor: 6.466

10.  Hybrid Dietary-Blood Inflammatory Profiles and Postmenopausal Breast Cancer: A Case-Control Study.

Authors:  Beata Stasiewicz; Lidia Wadolowska; Maciej Biernacki; Malgorzata Anna Slowinska; Marek Drozdowski
Journal:  Nutrients       Date:  2020-11-14       Impact factor: 5.717

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.